Evidence map›Paper›PMID 21853025›Full record

ArticlePloS one2011

A bayesian method for evaluating and discovering disease loci associations.

Xia Jiang, M Michael Barmada, Gregory F Cooper, Michael J Becich

Abstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xia JiangDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America. xij6@pitt.edu
M Michael Barmada
Gregory F Cooper
Michael J Becich

Funding

Predicting Patient Outcomes from Clinical and Genome-Wide DataR01LM010020 · NLM · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COOPER, GREGORY F. · 2009 to 2010
$1.2M
Detecting Genome Wide Epistasis with Efficient Bayesian Network LearningR00LM010822 · NLM · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JIANG, XIA · 2012 to 2014
$565k
Detecting Genome Wide Epistasis with Efficient Bayesian Network LearningK99LM010822 · NLM · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JIANG, XIA · 2010 to 2011
$180k
NLM NIH HHS 1K99LM010822-01NLM NIH HHS K99 LM010822NLM NIH HHS R00 LM010822NLM NIH HHS R01 LM010020NLM NIH HHS R01-LM010020
6 · The paper itself

Abstract

backgroundA genome-wide association study (GWAS) typically involves examining representative SNPs in individuals from some population. A GWAS data set can concern a million SNPs and may soon concern billions. Researchers investigate the association of each SNP individually with a disease, and it is becoming increasingly commonplace to also analyze multi-SNP associations. Techniques for handling so many hypotheses include the Bonferroni correction and recently developed bayesian methods. These methods can encounter problems. Most importantly, they are not applicable to a complex multi-locus hypothesis which has several competing hypotheses rather than only a null hypothesis. A method that computes the posterior probability of complex hypotheses is a pressing need. METHODOLOGY/

findingsWe introduce the bayesian network posterior probability (BNPP) method which addresses the difficulties. The method represents the relationship between a disease and SNPs using a directed acyclic graph (DAG) model, and computes the likelihood of such models using a bayesian network scoring criterion. The posterior probability of a hypothesis is computed based on the likelihoods of all competing hypotheses. The BNPP can not only be used to evaluate a hypothesis that has previously been discovered or suspected, but also to discover new disease loci associations. The results of experiments using simulated and real data sets are presented. Our results concerning simulated data sets indicate that the BNPP exhibits both better evaluation and discovery performance than does a p-value based method. For the real data sets, previous findings in the literature are confirmed and additional findings are found. CONCLUSIONS/SIGNIFICANCE: We conclude that the BNPP resolves a pressing problem by providing a way to compute the posterior probability of complex multi-locus hypotheses. A researcher can use the BNPP to determine the expected utility of investigating a hypothesis further. Furthermore, we conclude that the BNPP is a promising method for discovering disease loci associations.

Indexed as

Genetic Predisposition to DiseaseAlzheimer DiseaseBayes TheoremBreast NeoplasmsComputer SimulationDatabases, GeneticDecision MakingFemaleGene Expression RegulationGenetic Association StudiesGenetic LociHumansModels, GeneticPolymorphism, Single NucleotideROC Curve

Identifiers

PMID21853025
PMCPMC3154195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.